Vertex Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since December 2023 — Data Talk

Vertex Pharmaceuticals Incorporated (VRTX) is currently at $503.26, up $42.39 or 9.2%


--Would be highest close since April 30, 2025, when it closed at $509.50

--On pace for largest percent increase since Dec. 13, 2023, when it rose 13.23%

--Currently up two consecutive days; up 10.2% over this period

--Best two day stretch since the two days ending Dec. 14, 2023, when it rose 13.66%

--Up 1.29% month-to-date

--Up 11.01% year-to-date

--Down 2.61% from its all-time closing high of $516.74 on Nov. 8, 2024

--Up 3.06% from 52 weeks ago (March 11, 2025), when it closed at $488.34

--Down 2.04% from its 52-week closing high of $513.76 on March 17, 2025

--Up 37.3% from its 52-week closing low of $366.54 on Aug. 8, 2025

--Traded as high as $504.25; highest intraday level since May 5, 2025, when it hit $505.61

--Up 9.41% at today's intraday high; largest intraday percent increase since Dec. 13, 2023, when it rose as much as 13.49%

--Best performer in the S&P 500 today

--Best performer in the Nasdaq 100 today


All data as of 9:49:37 AM ET


Source: Dow Jones Market Data, FactSet


(END) Dow Jones Newswires

March 10, 2026 10:07 ET (14:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center